These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

After the float: Imperial Innovations

How will Imperial College London's newly floated tech-transfer affiliate invest its stock-market millions? After raising the money, now comes the fun part: spending it.
01 Aug 2006

The spin on electronics

It is a hard life being an electronics business, they just keep changing the science under you. This time around we have a combination of electronics and spin – and that has nothing to do with PR.
01 Aug 2006

Blue biotech emerges from the deep

Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans.
01 Aug 2006

Cytokine for treating autoimmune diseases ready for partnering

PharmaLinks, a business dedicated to commercialising pharmaceutical research, is looking for a development partner for an immunosuppressive cytokine with therapeutic potential in inflammatory diseases including rheumatoid arthritis, asthma, COPD and arteriosclerosis.
01 Aug 2006